Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1

Clinical trial NCT03845049 · TERMINATED

Trial details

NCT number: NCT03845049
Sponsor: Centre Hospitalier Universitaire Dijon
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Telangiectasia

Start date: 2019-07-03
Primary completion: 2025-03-26
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.